Genprex, Inc. — Form 8-K
Filed July 14, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Genprex implemented a 1-for-22 reverse stock split of its common stock, effective July 16, 2026. Each 22 shares held by stockholders were automatically combined into 1 share; fractional shares are rounded up to the nearest whole share. The number of authorized shares remains unchanged. This is a structural recapitalization with no change to the company's equity or operations.
Why this rating
Reverse split is routine corporate housekeeping—common for penny stocks to improve share price optics. No change to equity value, assets, or business fundamentals. Material only to existing shareholders' certificate counts.
See more from July 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.